UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Small-Sized mPEG-PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity Journal article
ACS Applied Materials and Interfaces, 2017,Volume: 9,Issue: 11,Page: 9516-9527
Authors:  Chen T.;  Li C.;  Li Y.;  Yi X.;  Wang R.;  Lee S.M.-Y.;  Zheng Y.
Favorite  |  View/Download:1/0  |  Submit date:2018/12/28
brain delivery  cellular uptake  fluorescence resonance energy transfer (FRET)  mPEG−PLGA nanoparticles  oral bioavailability  Schisantherin A  
Small-Sized mPEG PLGA Nanoparticles of Schisantherin A with Sustained Release for Enhanced Brain Uptake and Anti-Parkinsonian Activity Journal article
ACS APPLIED MATERIALS & INTERFACES, 2017,Volume: 9,Issue: 11,Page: 9516-9527
Authors:  Chen, Tongkai;  Li, Chuwen;  Li, Ye;  Yi, Xiang;  Wang, Ruibing;  Lee, Simon Ming-Yuen;  Zheng, Ying
Favorite  |  View/Download:14/0  |  Submit date:2018/10/30
Brain Delivery  Cellular Uptake  Fluorescence Resonance Energy Transfer (Fret)  Mpeg-plga Nanoparticles  Oral Bioavailability  Schisantherin a  
Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: A study of formulation optimization, toxicity, and pharmacokinetics Journal article
Oncotarget, 2017,Volume: 8,Issue: 7,Page: 12013-12030
Authors:  Wang Q.;  Wei N.;  Liu X.;  Chang A.;  Luo K.Q.
Favorite  |  View/Download:2/0  |  Submit date:2018/12/18
Acetyltanshinone Iia  Anticancer Drugs  Bioavailability  Mpeg-plga  Pharmacokinetics  Toxicity